| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 22.12.2004 (7068
dage). |
Ingen historik.
| Branche | | Computerprogrammering (620100). |
| Sidst opdateret den 24.12.2007 og
angivet som gældende fra 01.01.2008 (5963
dage). |
| Historik | Start | Stop |
|---|
| Computerprogrammering (620100) | 01.01.2008 | |
| Udvikling af kundespecifikt software og konsulentbistand i forbindelse med software (722200) | 10.01.2005 | 31.12.2007 |
| Uoplyst (980000) | 22.12.2004 | 09.01.2005 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 22.12.2004 (7068
dage). |
Ingen historik.
| Revisor | | KPMG P/S |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 19.12.2014 (3419
dage). |
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
| Navne | | QIAGEN AARHUS A/S. |
| Sidst opdateret den 29.01.2014 og
angivet som gældende fra 27.01.2014 (3745
dage). |
| Historik | Start | Stop |
|---|
| QIAGEN AARHUS A/S | 27.01.2014 | |
| CLC BIO A/S | 15.03.2005 | 26.01.2014 |
| GENIEMATICS A/S | 22.12.2004 | 14.03.2005 |
| Binavne | | Exiqon A/S. |
| Sidst opdateret den 14.03.2019 og
angivet som gældende fra 03.01.2019 (1943
dage). |
Ingen historik.
| Tegningsregel | | Selskabet tegnes af 1 direktør i forening med et bestyrelsesmedlem, 2 bestyrelsesmedlemmer i forening eller af den samlede bestyrelse. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 27.05.2014 (3625
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | 1 direktør + 1 bestyrelsesmedlem |
| 2 bestyrelsesmedlemmer + |
| bestyrelsen |
Ingen historik.
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:KPMG Statsautoriseret Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:25578198
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class C, medium-size enterprise
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants' International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion We have audited the financial statements of QIAGEN Århus A/S for the financial year 1 January – 31 December 2022 comprising income statement, balance sheet, statement of changes in equity, and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the Company's assets, liabilities and financial position at 31 December 2022 and of the results of the Company's operations for the financial year 1 January – 31 December 2022 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's review Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statement Act. We did not identify any material misstatement of the Management's review.
| Bibranche | | Forskning og eksperimentel udvikling indenfor bioteknologi. |
| Sidst opdateret den 13.04.2018
og
angivet som gældende fra 01.04.2018 (2220
dage). |
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration